Search Results
Search for other papers by Carmen Sydlik in
Google Scholar
PubMed
Search for other papers by Ilja Dubinski in
Google Scholar
PubMed
Search for other papers by Susanne Bechtold in
Google Scholar
PubMed
Search for other papers by Heinrich Schmidt in
Google Scholar
PubMed
, as triiodothyronine/free triiodothyronine (T3/fT3) levels may be low ( 1 , 2 ). In healthy individuals, fT3 levels can be stable over a wide range of corresponding TSH levels ( 3 ). The regulation of thyroid hormones is reflected in an adjusting fT3
School of Medicine, Ningbo University, Ningbo, China
Search for other papers by Qiankai Jin in
Google Scholar
PubMed
School of Medicine, Ningbo University, Ningbo, China
Search for other papers by Guoqing Huang in
Google Scholar
PubMed
School of Medicine, Ningbo University, Ningbo, China
Search for other papers by Xiaoqing Tian in
Google Scholar
PubMed
School of Medicine, Ningbo University, Ningbo, China
Search for other papers by Yimeng Shu in
Google Scholar
PubMed
School of Medicine, Ningbo University, Ningbo, China
Search for other papers by Ximisinuer Tusongtuoheti in
Google Scholar
PubMed
Search for other papers by Yushan Mao in
Google Scholar
PubMed
, and its evaluation in different regions and ethnicities is of importance. This study is part of the 2019 Zhejiang Zhenhai study, and the aim was to discuss the relationship between TSH, free triiodothyronine (FT3), FT4, and FT3/FT4 levels within the
Section of Pacing and Electrophysiology, Division of Cardiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China
Search for other papers by Ling Sun in
Google Scholar
PubMed
Search for other papers by Wenwu Zhu in
Google Scholar
PubMed
Search for other papers by Yuan Ji in
Google Scholar
PubMed
Search for other papers by Ailin Zou in
Google Scholar
PubMed
Dalian Medical University, Dalian, Liaoning, China
Search for other papers by Lipeng Mao in
Google Scholar
PubMed
Dalian Medical University, Dalian, Liaoning, China
Search for other papers by Boyu Chi in
Google Scholar
PubMed
Search for other papers by Jianguang Jiang in
Google Scholar
PubMed
Search for other papers by Xuejun Zhou in
Google Scholar
PubMed
Search for other papers by Qingjie Wang in
Google Scholar
PubMed
Search for other papers by Fengxiang Zhang in
Google Scholar
PubMed
.13(0.62, 2,12) 0.313 AKI, acute kidney injury; BNP, brain natriuretic peptide; DBP, diastolic blood pressure; FT3, free triiodothyronine; FT4, free thyroxine; LVEF, left ventricular ejection fraction; NSTEMI, non-ST segment elevation myocardial
Search for other papers by Till Ittermann in
Google Scholar
PubMed
Department of Zoology, Islamia College Peshawar (CU), Peshawar, Pakistan
Search for other papers by Rehman Mehmood Khattak in
Google Scholar
PubMed
Search for other papers by Marcello R P Markus in
Google Scholar
PubMed
Search for other papers by Jens-Peter Kühn in
Google Scholar
PubMed
Search for other papers by Marie-Luise Kromrey in
Google Scholar
PubMed
Search for other papers by Giovanni Targher in
Google Scholar
PubMed
Search for other papers by Antje Steveling in
Google Scholar
PubMed
DZHK (German Centre for Cardiovascular Research), Partner Site Greifswald, University Medicine, Greifswald, Germany
Search for other papers by Matthias Nauck in
Google Scholar
PubMed
Search for other papers by Henry Völzke in
Google Scholar
PubMed
-stimulating hormone (mIU/L) 1.19 (0.87, 1.60) 0.35 (0.25, 0.44) 3.88 (3.59, 5.27) Free triiodothyronine (fT3) (pmol/L) 4.63 (4.29, 5.05) 4.76 (4.35, 5.12) 4.45 (4.10, 4.80) Free thyroxine (fT4) (pmol/L) 13.3 (12.3, 14.4) 14.3 (13.0, 15
Search for other papers by Ayse Nurcan Cebeci in
Google Scholar
PubMed
Search for other papers by Vera Schempp in
Google Scholar
PubMed
Search for other papers by Katharina Förtsch in
Google Scholar
PubMed
Search for other papers by Bettina Gohlke in
Google Scholar
PubMed
Search for other papers by Michaela Marx in
Google Scholar
PubMed
Search for other papers by Helmuth-Guenther Dörr in
Google Scholar
PubMed
Search for other papers by Joachim Woelfle in
Google Scholar
PubMed
While subclinical or overt hypothyroidism are common in Down syndrome (DS); Graves’ disease (GD) is rare (ranges 0.6–3%). We aimed to evaluate the clinical features, course, and treatment of GD in children with DS and compare them with those without DS. Among 161 children with GD, 13 (8 female, 5 male) had DS (8%). Data were collected retrospectively from patients’ medical records. The mean age at diagnosis was 10.6 ± 4.5 years, with a female-to-male ratio 1.6:1. The main symptoms were weight loss (n = 6), increased irritability (n = 3), and increased sweating (n = 3). None had orbitopathy. Seven of 11 patients with a thyroid ultrasound at diagnosis had a goitre. On admission, all had thyroid-stimulating hormone (TSH) <0.01 mU/L (normal range (NR): 0.51–4.30), free triiodothyronine, free thyroxine (mean ± s.d .), and thyrotrophin receptor antibodies (median, range) were 22.2 ± 10.2 pmol/L (NR: 3.5–8.1), 50.2 ± 18.7 pmol/L (NR 12.6–20.9), and 17.0 (2.89–159.0) U/L (NR <1), respectively. Patients were treated either with methimazole (n = 10) or carbimazole (n = 3), a dose of 0.54 ± 0.36 mg/kg/day. The treatment was ‘block and replace’ in ten patients and ‘dose titration’ in three patients, with a mean duration of 43.4 ± 11.0 months. Of 13 patients, four are still receiving primary treatment, three are in remission, one patient had two medically treated recurrences, three underwent surgery without complications, and two patients were lost to follow-up. Our data show that the clinical course of GD in patients with DS was similar to those without DS and suggest that a prolonged medical therapy should be the preferred option.
Search for other papers by Xiaowen Zhang in
Google Scholar
PubMed
Department of Endocrinology and Metabolism, Drum Tower Clinical Medical College, Southeast University, Nanjing, China
Search for other papers by Chen Han in
Google Scholar
PubMed
Search for other papers by Hongwei Wang in
Google Scholar
PubMed
Search for other papers by Xinghong Sun in
Google Scholar
PubMed
Search for other papers by Xin Dou in
Google Scholar
PubMed
Search for other papers by Xueying He in
Google Scholar
PubMed
Search for other papers by Di Wu in
Google Scholar
PubMed
Search for other papers by Shanmei Shen in
Google Scholar
PubMed
Search for other papers by Dalong Zhu in
Google Scholar
PubMed
Search for other papers by Xinlin Zhang in
Google Scholar
PubMed
Search for other papers by Yan Bi in
Google Scholar
PubMed
smoking, duration of GD, and duration of TED were collected. Blood cell counts were obtained and NLR was calculated by dividing the absolute neutrophil count by the lymphocyte count. Serum TSH, free triiodothyronine, free thyroxine, and thyroid
Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia
Search for other papers by Katica Bajuk Studen in
Google Scholar
PubMed
Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia
Search for other papers by Simona Gaberšček in
Google Scholar
PubMed
Search for other papers by Edvard Pirnat in
Google Scholar
PubMed
Search for other papers by Nataša Bedernjak Bajuk in
Google Scholar
PubMed
Search for other papers by Andreja Vendramin in
Google Scholar
PubMed
Search for other papers by Vito Majcen in
Google Scholar
PubMed
Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia
Search for other papers by Katja Zaletel in
Google Scholar
PubMed
ultrasound, and at least one of the following – thyroid swelling; pain and tenderness of the thyroid gland/lobe; decreased serum level of thyrotropin (TSH); elevated serum level of free thyroxine (free T 4 ) and/or free triiodothyronine (free T 3
Search for other papers by Ru-Xuan Zhao in
Google Scholar
PubMed
Search for other papers by Ting-Ting Shi in
Google Scholar
PubMed
Search for other papers by Sha Luo in
Google Scholar
PubMed
Search for other papers by Yun-Fu Liu in
Google Scholar
PubMed
Search for other papers by Zhong Xin in
Google Scholar
PubMed
Search for other papers by Jin-Kui Yang in
Google Scholar
PubMed
drug use, and history of smoking were recorded. Clinical data including serum free triiodothyronine 3 (FT3), free triiodothyronine 4 (FT4), thyroid-stimulating hormone (TSH), and thyrotropin receptor antibody (TRAb) levels were measured to assess
Search for other papers by Xiaoya Zheng in
Google Scholar
PubMed
Search for other papers by Heng Xiao in
Google Scholar
PubMed
Search for other papers by Jian Long in
Google Scholar
PubMed
Search for other papers by Qiang Wei in
Google Scholar
PubMed
Search for other papers by Liping Liu in
Google Scholar
PubMed
Search for other papers by Liping Zan in
Google Scholar
PubMed
Search for other papers by Wei Ren in
Google Scholar
PubMed
free triiodothyronine (FT3), free thyroxine (FT4), ultrasensitive thyroid-stimulating hormone (uTSH), and thyroid antithyroglobulin autoantibody (TgAb) were detected with an immunochemical-automated analyzer (Beckman Coulter UniCelDxI 800; Beckman
Search for other papers by Yuegui Wang in
Google Scholar
PubMed
Search for other papers by Liwei Hong in
Google Scholar
PubMed
School of Clinical Medicine, Fujian Medical University, Fuzhou, Fujian, China
Search for other papers by Caiyun Yang in
Google Scholar
PubMed
Quanzhou Medical College, Quanzhou, Fujian, China
Search for other papers by Guorong Lv in
Google Scholar
PubMed
Search for other papers by Kangjian Wang in
Google Scholar
PubMed
Search for other papers by Xuepeng Huang in
Google Scholar
PubMed
Search for other papers by Haolin Shen in
Google Scholar
PubMed
triiodothyronine, and thyrotropin receptor antibody Levels of free triiodothyronine (FT3), free thyroxine (FT4), and thyrotropin receptor antibody (TRAb) in patients' venous blood were measured using an electroluminescent immunoassay (Beckman, DXI800) after